mRNA Vaccine Market Report

Global mRNA Vaccine Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 08, 2022
  • PAGES：168
  • REPORT CODE：GMM847306
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • mRNA Vaccine market report explains the definition, types, applications, major countries, and major players of the mRNA Vaccine market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • BioNTech

    • eTheRNA

    • Moderna Therapeutics

    • Tiba Biotechnology

    • Argos Therapeutics

    • Translate Bio

    • CureVac

    • In-Cell-Art

    • Ethris

    • Sangamo Therapeutics

    By Type:

    • Standardization Of Cancer Treatment MRNA Vaccine

    • Individualized Cancer Treatment MRNA Vaccine

    • Infectious Disease Treatment MRNA Vaccine

    • Infection Prevention MRNA Vaccine

    By End-User:

    • Infectious Disease

    • Cancer

    • Other

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global mRNA Vaccine Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 mRNA Vaccine Outlook to 2028- Original Forecasts

    • 2.2 mRNA Vaccine Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term mRNA Vaccine Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global mRNA Vaccine Market- Recent Developments

    • 6.1 mRNA Vaccine Market News and Developments

    • 6.2 mRNA Vaccine Market Deals Landscape

    7 mRNA Vaccine Raw Materials and Cost Structure Analysis

    • 7.1 mRNA Vaccine Key Raw Materials

    • 7.2 mRNA Vaccine Price Trend of Key Raw Materials

    • 7.3 mRNA Vaccine Key Suppliers of Raw Materials

    • 7.4 mRNA Vaccine Market Concentration Rate of Raw Materials

    • 7.5 mRNA Vaccine Cost Structure Analysis

      • 7.5.1 mRNA Vaccine Raw Materials Analysis

      • 7.5.2 mRNA Vaccine Labor Cost Analysis

      • 7.5.3 mRNA Vaccine Manufacturing Expenses Analysis

    8 Global mRNA Vaccine Import and Export Analysis (Top 10 Countries)

    • 8.1 Global mRNA Vaccine Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global mRNA Vaccine Export by Region (Top 10 Countries) (2017-2028)

    9 Global mRNA Vaccine Market Outlook by Types and Applications to 2022

    • 9.1 Global mRNA Vaccine Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Standardization Of Cancer Treatment MRNA Vaccine Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Individualized Cancer Treatment MRNA Vaccine Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Infectious Disease Treatment MRNA Vaccine Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Infection Prevention MRNA Vaccine Consumption and Growth Rate (2017-2022)

    • 9.2 Global mRNA Vaccine Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Infectious Disease Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Other Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise mRNA Vaccine Market Analysis and Outlook till 2022

    • 10.1 Global mRNA Vaccine Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States mRNA Vaccine Consumption (2017-2022)

      • 10.2.2 Canada mRNA Vaccine Consumption (2017-2022)

      • 10.2.3 Mexico mRNA Vaccine Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany mRNA Vaccine Consumption (2017-2022)

      • 10.3.2 UK mRNA Vaccine Consumption (2017-2022)

      • 10.3.3 Spain mRNA Vaccine Consumption (2017-2022)

      • 10.3.4 Belgium mRNA Vaccine Consumption (2017-2022)

      • 10.3.5 France mRNA Vaccine Consumption (2017-2022)

      • 10.3.6 Italy mRNA Vaccine Consumption (2017-2022)

      • 10.3.7 Denmark mRNA Vaccine Consumption (2017-2022)

      • 10.3.8 Finland mRNA Vaccine Consumption (2017-2022)

      • 10.3.9 Norway mRNA Vaccine Consumption (2017-2022)

      • 10.3.10 Sweden mRNA Vaccine Consumption (2017-2022)

      • 10.3.11 Poland mRNA Vaccine Consumption (2017-2022)

      • 10.3.12 Russia mRNA Vaccine Consumption (2017-2022)

      • 10.3.13 Turkey mRNA Vaccine Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China mRNA Vaccine Consumption (2017-2022)

      • 10.4.2 Japan mRNA Vaccine Consumption (2017-2022)

      • 10.4.3 India mRNA Vaccine Consumption (2017-2022)

      • 10.4.4 South Korea mRNA Vaccine Consumption (2017-2022)

      • 10.4.5 Pakistan mRNA Vaccine Consumption (2017-2022)

      • 10.4.6 Bangladesh mRNA Vaccine Consumption (2017-2022)

      • 10.4.7 Indonesia mRNA Vaccine Consumption (2017-2022)

      • 10.4.8 Thailand mRNA Vaccine Consumption (2017-2022)

      • 10.4.9 Singapore mRNA Vaccine Consumption (2017-2022)

      • 10.4.10 Malaysia mRNA Vaccine Consumption (2017-2022)

      • 10.4.11 Philippines mRNA Vaccine Consumption (2017-2022)

      • 10.4.12 Vietnam mRNA Vaccine Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil mRNA Vaccine Consumption (2017-2022)

      • 10.5.2 Colombia mRNA Vaccine Consumption (2017-2022)

      • 10.5.3 Chile mRNA Vaccine Consumption (2017-2022)

      • 10.5.4 Argentina mRNA Vaccine Consumption (2017-2022)

      • 10.5.5 Venezuela mRNA Vaccine Consumption (2017-2022)

      • 10.5.6 Peru mRNA Vaccine Consumption (2017-2022)

      • 10.5.7 Puerto Rico mRNA Vaccine Consumption (2017-2022)

      • 10.5.8 Ecuador mRNA Vaccine Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain mRNA Vaccine Consumption (2017-2022)

      • 10.6.2 Kuwait mRNA Vaccine Consumption (2017-2022)

      • 10.6.3 Oman mRNA Vaccine Consumption (2017-2022)

      • 10.6.4 Qatar mRNA Vaccine Consumption (2017-2022)

      • 10.6.5 Saudi Arabia mRNA Vaccine Consumption (2017-2022)

      • 10.6.6 United Arab Emirates mRNA Vaccine Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria mRNA Vaccine Consumption (2017-2022)

      • 10.7.2 South Africa mRNA Vaccine Consumption (2017-2022)

      • 10.7.3 Egypt mRNA Vaccine Consumption (2017-2022)

      • 10.7.4 Algeria mRNA Vaccine Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia mRNA Vaccine Consumption (2017-2022)

      • 10.8.2 New Zealand mRNA Vaccine Consumption (2017-2022)

    11 Global mRNA Vaccine Competitive Analysis

    • 11.1 BioNTech

      • 11.1.1 BioNTech Company Details

      • 11.1.2 BioNTech mRNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 BioNTech mRNA Vaccine Main Business and Markets Served

      • 11.1.4 BioNTech mRNA Vaccine Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 eTheRNA

      • 11.2.1 eTheRNA Company Details

      • 11.2.2 eTheRNA mRNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 eTheRNA mRNA Vaccine Main Business and Markets Served

      • 11.2.4 eTheRNA mRNA Vaccine Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Moderna Therapeutics

      • 11.3.1 Moderna Therapeutics Company Details

      • 11.3.2 Moderna Therapeutics mRNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Moderna Therapeutics mRNA Vaccine Main Business and Markets Served

      • 11.3.4 Moderna Therapeutics mRNA Vaccine Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Tiba Biotechnology

      • 11.4.1 Tiba Biotechnology Company Details

      • 11.4.2 Tiba Biotechnology mRNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Tiba Biotechnology mRNA Vaccine Main Business and Markets Served

      • 11.4.4 Tiba Biotechnology mRNA Vaccine Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Argos Therapeutics

      • 11.5.1 Argos Therapeutics Company Details

      • 11.5.2 Argos Therapeutics mRNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Argos Therapeutics mRNA Vaccine Main Business and Markets Served

      • 11.5.4 Argos Therapeutics mRNA Vaccine Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Translate Bio

      • 11.6.1 Translate Bio Company Details

      • 11.6.2 Translate Bio mRNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Translate Bio mRNA Vaccine Main Business and Markets Served

      • 11.6.4 Translate Bio mRNA Vaccine Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 CureVac

      • 11.7.1 CureVac Company Details

      • 11.7.2 CureVac mRNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 CureVac mRNA Vaccine Main Business and Markets Served

      • 11.7.4 CureVac mRNA Vaccine Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 In-Cell-Art

      • 11.8.1 In-Cell-Art Company Details

      • 11.8.2 In-Cell-Art mRNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 In-Cell-Art mRNA Vaccine Main Business and Markets Served

      • 11.8.4 In-Cell-Art mRNA Vaccine Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Ethris

      • 11.9.1 Ethris Company Details

      • 11.9.2 Ethris mRNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Ethris mRNA Vaccine Main Business and Markets Served

      • 11.9.4 Ethris mRNA Vaccine Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Sangamo Therapeutics

      • 11.10.1 Sangamo Therapeutics Company Details

      • 11.10.2 Sangamo Therapeutics mRNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Sangamo Therapeutics mRNA Vaccine Main Business and Markets Served

      • 11.10.4 Sangamo Therapeutics mRNA Vaccine Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    12 Global mRNA Vaccine Market Outlook by Types and Applications to 2028

    • 12.1 Global mRNA Vaccine Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Standardization Of Cancer Treatment MRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Individualized Cancer Treatment MRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Infectious Disease Treatment MRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Infection Prevention MRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global mRNA Vaccine Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Infectious Disease Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise mRNA Vaccine Market Analysis and Outlook to 2028

    • 13.1 Global mRNA Vaccine Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States mRNA Vaccine Consumption Forecast (2022-2028)

      • 13.2.2 Canada mRNA Vaccine Consumption Forecast (2022-2028)

      • 13.2.3 Mexico mRNA Vaccine Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany mRNA Vaccine Consumption Forecast (2022-2028)

      • 13.3.2 UK mRNA Vaccine Consumption Forecast (2022-2028)

      • 13.3.3 Spain mRNA Vaccine Consumption Forecast (2022-2028)

      • 13.3.4 Belgium mRNA Vaccine Consumption Forecast (2022-2028)

      • 13.3.5 France mRNA Vaccine Consumption Forecast (2022-2028)

      • 13.3.6 Italy mRNA Vaccine Consumption Forecast (2022-2028)

      • 13.3.7 Denmark mRNA Vaccine Consumption Forecast (2022-2028)

      • 13.3.8 Finland mRNA Vaccine Consumption Forecast (2022-2028)

      • 13.3.9 Norway mRNA Vaccine Consumption Forecast (2022-2028)

      • 13.3.10 Sweden mRNA Vaccine Consumption Forecast (2022-2028)

      • 13.3.11 Poland mRNA Vaccine Consumption Forecast (2022-2028)

      • 13.3.12 Russia mRNA Vaccine Consumption Forecast (2022-2028)

      • 13.3.13 Turkey mRNA Vaccine Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China mRNA Vaccine Consumption Forecast (2022-2028)

      • 13.4.2 Japan mRNA Vaccine Consumption Forecast (2022-2028)

      • 13.4.3 India mRNA Vaccine Consumption Forecast (2022-2028)

      • 13.4.4 South Korea mRNA Vaccine Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan mRNA Vaccine Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh mRNA Vaccine Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia mRNA Vaccine Consumption Forecast (2022-2028)

      • 13.4.8 Thailand mRNA Vaccine Consumption Forecast (2022-2028)

      • 13.4.9 Singapore mRNA Vaccine Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia mRNA Vaccine Consumption Forecast (2022-2028)

      • 13.4.11 Philippines mRNA Vaccine Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam mRNA Vaccine Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil mRNA Vaccine Consumption Forecast (2022-2028)

      • 13.5.2 Colombia mRNA Vaccine Consumption Forecast (2022-2028)

      • 13.5.3 Chile mRNA Vaccine Consumption Forecast (2022-2028)

      • 13.5.4 Argentina mRNA Vaccine Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela mRNA Vaccine Consumption Forecast (2022-2028)

      • 13.5.6 Peru mRNA Vaccine Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico mRNA Vaccine Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador mRNA Vaccine Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain mRNA Vaccine Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait mRNA Vaccine Consumption Forecast (2022-2028)

      • 13.6.3 Oman mRNA Vaccine Consumption Forecast (2022-2028)

      • 13.6.4 Qatar mRNA Vaccine Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia mRNA Vaccine Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates mRNA Vaccine Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria mRNA Vaccine Consumption Forecast (2022-2028)

      • 13.7.2 South Africa mRNA Vaccine Consumption Forecast (2022-2028)

      • 13.7.3 Egypt mRNA Vaccine Consumption Forecast (2022-2028)

      • 13.7.4 Algeria mRNA Vaccine Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia mRNA Vaccine Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand mRNA Vaccine Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of mRNA Vaccine

    • Figure of mRNA Vaccine Picture

    • Table Global mRNA Vaccine Import by Region (Top 10 Countries) (2017-2028)

    • Table Global mRNA Vaccine Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Standardization Of Cancer Treatment MRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Global Individualized Cancer Treatment MRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Global Infectious Disease Treatment MRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Global Infection Prevention MRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Global Infectious Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global mRNA Vaccine Consumption by Country (2017-2022)

    • Table North America mRNA Vaccine Consumption by Country (2017-2022)

    • Figure United States mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Canada mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Mexico mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Table Europe mRNA Vaccine Consumption by Country (2017-2022)

    • Figure Germany mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure UK mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Spain mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Belgium mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure France mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Italy mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Denmark mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Finland mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Norway mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Sweden mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Poland mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Russia mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Turkey mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Table APAC mRNA Vaccine Consumption by Country (2017-2022)

    • Figure China mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Japan mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure India mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Korea mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Pakistan mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Indonesia mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Thailand mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Singapore mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Malaysia mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Philippines mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Vietnam mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Table South America mRNA Vaccine Consumption by Country (2017-2022)

    • Figure Brazil mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Colombia mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Chile mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Argentina mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Venezuela mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Peru mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Ecuador mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Table GCC mRNA Vaccine Consumption by Country (2017-2022)

    • Figure Bahrain mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Kuwait mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Oman mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Qatar mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Table Africa mRNA Vaccine Consumption by Country (2017-2022)

    • Figure Nigeria mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Africa mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Egypt mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Algeria mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Table Oceania mRNA Vaccine Consumption by Country (2017-2022)

    • Figure Australia mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure New Zealand mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Table BioNTech Company Details

    • Table BioNTech mRNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioNTech mRNA Vaccine Main Business and Markets Served

    • Table BioNTech mRNA Vaccine Product Portfolio

    • Table eTheRNA Company Details

    • Table eTheRNA mRNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table eTheRNA mRNA Vaccine Main Business and Markets Served

    • Table eTheRNA mRNA Vaccine Product Portfolio

    • Table Moderna Therapeutics Company Details

    • Table Moderna Therapeutics mRNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Moderna Therapeutics mRNA Vaccine Main Business and Markets Served

    • Table Moderna Therapeutics mRNA Vaccine Product Portfolio

    • Table Tiba Biotechnology Company Details

    • Table Tiba Biotechnology mRNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Tiba Biotechnology mRNA Vaccine Main Business and Markets Served

    • Table Tiba Biotechnology mRNA Vaccine Product Portfolio

    • Table Argos Therapeutics Company Details

    • Table Argos Therapeutics mRNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Argos Therapeutics mRNA Vaccine Main Business and Markets Served

    • Table Argos Therapeutics mRNA Vaccine Product Portfolio

    • Table Translate Bio Company Details

    • Table Translate Bio mRNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Translate Bio mRNA Vaccine Main Business and Markets Served

    • Table Translate Bio mRNA Vaccine Product Portfolio

    • Table CureVac Company Details

    • Table CureVac mRNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table CureVac mRNA Vaccine Main Business and Markets Served

    • Table CureVac mRNA Vaccine Product Portfolio

    • Table In-Cell-Art Company Details

    • Table In-Cell-Art mRNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table In-Cell-Art mRNA Vaccine Main Business and Markets Served

    • Table In-Cell-Art mRNA Vaccine Product Portfolio

    • Table Ethris Company Details

    • Table Ethris mRNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ethris mRNA Vaccine Main Business and Markets Served

    • Table Ethris mRNA Vaccine Product Portfolio

    • Table Sangamo Therapeutics Company Details

    • Table Sangamo Therapeutics mRNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sangamo Therapeutics mRNA Vaccine Main Business and Markets Served

    • Table Sangamo Therapeutics mRNA Vaccine Product Portfolio

    • Figure Global Standardization Of Cancer Treatment MRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Individualized Cancer Treatment MRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Infectious Disease Treatment MRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Infection Prevention MRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Infectious Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global mRNA Vaccine Consumption Forecast by Country (2022-2028)

    • Table North America mRNA Vaccine Consumption Forecast by Country (2022-2028)

    • Figure United States mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe mRNA Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Germany mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure France mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC mRNA Vaccine Consumption Forecast by Country (2022-2028)

    • Figure China mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure India mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table South America mRNA Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Brazil mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC mRNA Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Bahrain mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa mRNA Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Nigeria mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania mRNA Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Australia mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US